Patents by Inventor Nada Bejar

Nada Bejar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARDIAC CELL PROLIFERATION BY ADMINISTERING INHIBITORS OF SAV1, NF2, MOB1 AND/OR MUTANT SRF
    Publication number: 20230193267
    Abstract: Disclosed are DsiRNA inhibitors for the genes encoding SAV1, NF2 and MOB1, which cause proliferation of cardiomyocytes on administration to a mammal. The DsiRNA inhibitors can also be administered with a mutant SRF(153-A3) or an mRNA encoding it, and/or Yap5SA (a Yap mutant) or an encoding mRNA, which enhance the proliferative effect on cardiomyocytes. Mutant SRF(153-A3) with Yap5SA alone also induce myocyte replication.
    Type: Application
    Filed: October 19, 2022
    Publication date: June 22, 2023
    Inventors: Robert Joel Schwartz, Nada Bejar